Jennifer Woyach
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT07557056) | Jennifer Woyach | 2026-09-01 |
| Pirtobrutinib for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia (NCT07685717) | Jennifer Woyach | 2026-08-01 |
| Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization (NCT04439006) | Jennifer Woyach | 2020-10-23 |
| Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia (NCT03447808) | Jennifer Woyach | 2018-08-16 |
Track Jennifer Woyach automatically
Every clearance here is in the API, with alerts when new ones post.